Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
Authors:
- Brian SongBSBrian Song
- Heineken QueenHQHeineken Queen
- Sarah F. FerrisSFSarah F. Ferris
- Reliza McGinnisRMReliza McGinnis
- Chaitanya KaranamCKChaitanya Karanam
- Natalie GattenoNGNatalie Gatteno
- Katherine BuglakKBKatherine Buglak
- Hanna KimHKHanna Kim
- Jintao XuJXJintao Xu
- Kristie D. GoughenourKGKristie D. Goughenour
- Zhen XuZXZhen Xu
- Michal A. OlszewskiMichal A. Olszewski
- 19 March 2025
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 24 (7) , 1088-1098
Abstract
Histotripsy-focused ultrasound treatment gives rise to systemic antitumor immune responses. We investigated whether histotripsy effects on immunosuppressive tumor hypoxia were a potential mechanism for these immunostimulatory effects. Immunocompetent or CD8-deficient C57BL/6 mice with flank B16F10 or YUMM1.7 melanoma tumors underwent sham or subtotal histotripsy. Tumor growth, immune cell infiltration, and intratumoral hypoxia responses were examined using flow cytometry and fluorescence microscopy. Chemokine receptor CXCR3 and hypoxia-inducible factor-1α (HIF1α) were intercepted with antibodies and inhibitors to assess their roles in immune responses after histotripsy. Histotripsy-treated tumors exhibited rapid loss of intratumoral hypoxia and suppression of HIF1α and downstream prosurvival proteins. Histotripsy was followed by intratumoral upregulation of the CXCR3 ligand CXCL10 and CXCR3+/CD8+ T-cell infiltration. Tumor growth inhibition by histotripsy was significantly diminished in CD8-deficient mice and mice receiving anti-CXCR3 mAb. Post-histotripsy inhibition of hypoxia and tumor growth eventually receded in parallel with cessation of CD8+ T-cell influx, and pharmacologic HIF1α suppression with the MEK inhibitor trametinib substantially augmented the therapeutic effects of histotripsy. Transient abrogation of intratumoral hypoxia and HIF1α-associated hypoxia responses is mechanistically linked with intratumoral infiltration of activated CXCR3+/CD8+ T cells via CXCL10–CXCR3 engagement. These findings suggest that the immune effects of histotripsy may be regulated by hypoxia abrogation and that pharmacologic hypoxia abrogation could potentiate the immunotherapeutic effects of histotripsy.Keywords
All Related Versions
Funding Information
- Focused Ultrasound Foundation (FUS 1285)
- University of Michigan (PRR U078622)
- U.S. Department of Veterans Affairs (CDA2)
- National Institutes of Health (R01CA269394-01A1)
- U.S. Department of Veterans Affairs (1I01BX001619-05)
- U.S. Department of Veterans Affairs (1I01BX000656, IK6BX005966)
- National Institutes of Health (R01CA211217)
- National Institute of Allergy and Infectious Diseases (T32-AI007413)
- Horace H. Rackham School of Graduate Studies, University of Michigan
- University of Michigan
This publication has 33 references indexed in Scilit:
- HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, −10 and −11Biomedicine & Pharmacotherapy, 2024
- Sono-activated materials for enhancing focused ultrasound ablation: Design and application in biomedicineActa Biomaterialia, 2023
- A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistanceNature Immunology, 2022
- Hypoxia as a driver of resistance to immunotherapyDrug Resistance Updates, 2021
- The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanomaBiomedicine & Pharmacotherapy, 2021
- Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapyOncogene, 2021
- Investigation of the Potential Immunological Effects of Boiling Histotripsy for Cancer TreatmentAdvanced Therapeutics, 2020
- Vascular Endothelial Growth Factor Signaling in Hypoxia and InflammationJournal of Neuroimmune Pharmacology, 2014
- Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3' flanking regionGene, 2008
- Hypoxia in cancer: significance and impact on clinical outcomeCancer and Metastasis Reviews, 2007